Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
<div><p>PRAME or PReferentially expressed Antigen in Melanoma is a testis-selective cancer testis antigen (CTA) with restricted expression in somatic tissues and re-expression in various cancers. It is one of the most widely studied CTAs and has been associated with the outcome and risk...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2019
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|